1 |
Maaser C, Sturm A, Vavricka SR, et al.ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications[J]. J Crohns Colitis, 2019, 13(2): 144-164.
|
2 |
Sturm A, Maaser C, Calabrese E, et al.ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects[J]. J Crohns Colitis, 2019, 13(3): 273-284.
|
3 |
Jeong DY, Kim S, Son MJ, et al.Induction and maintenance treatment of inflammatory bowel disease: A comprehensive review[J]. Autoimmun Rev, 2019, 18(5): 439-454.
|
4 |
中华医学会消化病学分会炎症性肠病学组.炎症性肠病诊断与治疗的共识意见(2018年,北京)[J].中华消化杂志,2018,38(5):292-311.
|
5 |
Harbord M, Eliakim R, Bettenworth D, et al.Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis.Part 2: Current Management[J]. J Crohns Colitis, 2017, 11(7): 769-784.
|
6 |
Peyrin-Biroulet L, Bouhnik Y, Roblin X, et al.French national consensus clinical guidelines for the management of Crohn′s disease[J]. Dig Liver Dis, 2017, 49(4): 368-377.
|
7 |
Santos AL, Coelho R, Silva M, et al.Infectious proctitis: a necessary differential diagnosis in ulcerative colitis[J]. Int J Colorectal Dis, 2019, 34(2): 359-362.
|
8 |
Craxford L, Fox A. Lymphogranuloma venereum: a rare and forgotten cause of rectal stricture formation[J]. Int J STD AIDS, 2018, 29(11): 1133-1135.
|
9 |
Onal IK, Kekilli M, Tanoglu A, et al.Tuberculosis and Crohn′s Disease Revisited[J]. J Coll Physicians Surg Pak, 2015, 25(6): 443-448.
|
10 |
Park DI, Hisamatsu T, Chen M, et al.Asian Organization for Crohn′s and Colitis and Asia Pacific Association of Gastroenterology consensus on tuberculosis infection in patients with inflammatory bowel disease receiving anti-tumor necrosis factor treatment.Part 2: Management[J]. J Gastroenterol Hepatol, 2018, 33(1): 30-36.
|
11 |
Kedia S, Das P, Madhusudhan KS, et al.Differentiating Crohn′s disease from intestinal tuberculosis[J]. World J Gastroenterol, 2019, 25(4): 418-432.
|
12 |
巫协宁,吴坚炯.克罗恩病和自身免疫[J].胃肠病学和肝病学杂志,2018,27 (10):1081-1085.
|
13 |
周颖婷,吴坚炯.盐酸舍曲林治疗溃疡性结肠炎伴抑郁的疗效[J].中华消化杂志,2015,35(9):595-598.
|
14 |
Barreiro-de Acosta M, Marín-Jiménez I, Panadero A, et al.Recommendations of the Spanish Working Group on Crohn′s Disease and Ulcerative Colitis (GETECCU) and the Association of Crohn′s Disease and Ulcerative Colitis Patients (ACCU) in the management of psychological problems in Inflammatory Bowel Disease patients[J]. Gastroenterol Hepatol, 2018, 41 (2): 118-127.
|
15 |
Kredel LI, Schneidereit O, Hoffmann JC, et al.Guideline recommendations for treatment of patients with inflammatory bowel diseases are not implemented in clinical practice-results of a non-representative survey[J]. Int J Colorectal Dis, 2019, 34(3): 431-440.
|
16 |
Brown SR, Fearnhead NS, Faiz OD, et al.The Association of Coloproctology of Great Britain and Ireland consensus guidelines in surgery for inflammatory bowel disease[J]. Colorectal Dis, 2018, 20 Suppl 8: 3-117.
|
17 |
中华医学会消化病学分会炎症性肠病学组.建立全国通用的炎症性肠病诊治过程的关键性质量控制指标的共识意见[J].中华炎性肠病杂志,2017,1(1):12-19.
|
18 |
Jeon SR, Chai J, Kim C, et al.Current Evidence for the Management of Inflammatory Bowel Diseases Using Fecal Microbiota Transplantation[J]. Curr Infect Dis Rep, 2018, 20(8): 21.
|
19 |
Verstockt B, Ferrante M, Vermeire S, et al.New treatment options for inflammatory bowel diseases[J]. J Gastroenterol, 2018, 53(5): 585-590.
|
20 |
Hibi T, Panaccione R, Katafuchi M, et al.The 5C Concept and 5S Principles in Inflammatory Bowel Disease Management[J]. J Crohns Colitis, 2017, 11(11): 1302-1308.
|